✦ LIBER ✦

Bioavailability of ridogrel administered orally and rectally to patients with ulcerative colitis

✍ Scribed by H.M. van Dullemen; S.H.A. Tytgat; M. Strijbos; J. v.d. Brande; B. Hazelhoff; G.N.J. Tytgat

Book ID: 118881049
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 160 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)28039-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bioavailability and therapeutic activity

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

✍ P. B. MINER JR; R. S. GEARY; J. MATSON; E. CHUANG; S. XIA; B. F. BAKER; M. K. WE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Comparative pharmacokinetics of sulphasa

Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis

✍ H. Allgayer; W. Kruis; J. Eisenburg; G. Paumgartner 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 290 KB

Using optical markers of nondysplastic r

Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia

✍ Rajan K. Bista; Teresa A. Brentnall; Mary P. Bronner; Christopher J. Langmead; R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

Background: Current surveillance guidelines for patients with long-standing ulcerative colitis (UC) recommend repeated colonoscopy with random biopsies, which is time-consuming, discomforting, and expensive. A less invasive strategy is to identify neoplasia by analyzing biomarkers from the more acce

Oral bioavailability of omeprazole befor

Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.

✍ MS Ching; GW Mihaly; PW Angus; DJ Morgan; S. Devenish-Meares; ND Yeomans; RA Sma 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 881 KB

TREATMENT OF ULCERATIVE COLITIS WITH ORA

TREATMENT OF ULCERATIVE COLITIS WITH ORAL 5-AMINOSALICYLIC ACID IN PATIENTS UNABLE TO TAKE SULPHASALAZINE

✍ Dew, M.J.; Harries, A.D.; Evans, B.K.; Rhodes, J. 📂 Article 📅 1983 🏛 The Lancet 🌐 English ⚖ 158 KB

Phase I, bioavailability, and pharmacoki

Phase I, bioavailability, and pharmacokinetic study of oral dosage of CCI-779 administered to patients with advanced solid malignancies

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 145 KB